Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.This article was originally published on […]
Patients living in linguistically discordant long-term care homes in Ontario are at higher odds of being inappropriately prescribed psychosis medication, says a new University of Ottawa study highlighting the importance of delivering care in the […]
Children born to mothers who take antiseizure medications to manage seizures and psychiatric conditions during pregnancy may face increased risks of neurodevelopmental conditions, according to new data from researchers at Drexel’s Dornsife School of Public […]
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use.This article was originally published on MedicalXpress.com
The U.S. Food and Drug Administration has approved Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.This article was originally published on MedicalXpress.com
In 2017, the CONSORT-CHM Formulas 2017 extension was introduced to enhance the reporting transparency of randomized controlled trials (RCTs) involving Chinese herbal medicine (CHM) formulas. This development aimed to detail the rationale, design, analysis, and […]
Europe’s medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer’s disease, reversing an earlier decision not to give it the green light.This article was originally published on MedicalXpress.com
In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain and […]
A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat neuropathic pain—increased the risk of hip fractures, especially in older patients who were frail or had kidney […]
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, were associated with fewer […]
© 2025 SimplyWell.ca